M&A Deal Summary |
|
---|---|
Date | 2023-01-17 |
Target | Neovasc |
Sector | Medical Products |
Buyer(s) | ShockWave Medical |
Deal Type | Add-on Acquisition |
Deal Value | 100M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2009 |
Sector | Life Science |
Employees | 1,400 |
Revenue | 730M USD (2023) |
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). ShockWave Medical was founded in 2009 and is based in Santa Clara, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (British Columbia) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2023) | 1 of 1 |
Size (of disclosed) | 1 of 1 |